345 results on '"Fischereder M."'
Search Results
2. Chronische Nierenerkrankung
3. Autoren
4. Chronische Nierenerkrankung
5. Autoren
6. Autosomal-dominante polyzystische Nierenerkrankung: Neue pathophysiologische und therapeutische Aspekte
7. Diabetes und Dialyse
8. Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial
9. Angiomyolipome bei tuberöser Sklerose: Diagnose und Therapie
10. Kapitel 14 - Chronische Nierenerkrankung
11. C1Q-BINDING ABILITY OF DONOR-SPECIFIC ANTI-HLA ANTIBODIES FACILITATES THE IDENTIFICATION OF HARMFUL ANTIBODIES ONLY PRE-TRANSPLANT: V043
12. Spiegelmer Inhibition of MCP-1/CCR2 – Potential as an Adjunct Immunosuppressive Therapy in Transplantation
13. Calcineurin Inhibitor-Free Immunosuppressive Strategy in Elderly Recipients of Renal Allografts From Deceased Donors: 1-Year Results From a Prospective Single Center Trial
14. CT perfusion technique for assessment of early kidney allograft dysfunction: preliminary results
15. The Source Matters: No Impact of the CCL2/MCP-1-1-2518G Polymorphism of the Donor on Renal Allograft Outcome During the First Year After Transplantation
16. Nephroprotektion bei Diabetes mellitus: ACE-Inhibition und zusätzlich Angiotensin-Rezeptorblocker oder Mineralokortikoidantagonist?
17. Tuberöse Hirnsklerose mit gleichzeitiger Neurofibromatose Typ 1: Auswirkungen einer Rapamycintherapie auf den Epilepsieverlauf
18. ACUTE REJECTION IN MURINE RENAL TRANSPLANTATION IS ALLEVIATED BY A NOVEL INHIBITOR OF THE MCP1/CCR2 SIGNALING PATHWAY: V30
19. Desensitization in Incompatible Living Kidney Donor Kidney Transplantation — A Single Center Experience.: Abstract# A183
20. Five-Year Follow-up After Late Conversion From Calcineurin Inhibitors to Sirolimus in Patients With Chronic Renal Allograft Dysfunction
21. Acquired combined factor X and XII deficiency with isolated bleeding complications in a patient with AL amyloidosis
22. HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy
23. Conversion From Calcineurin Inhibitors to Sirolimus in Patients With Chronic Renal Allograft Dysfunction
24. Conversion to Sirolimus in Renal Transplant Recipients with Malignancies.: Abstract# 1283: Poster Board #-Session: P150-III
25. Spiegelmer Based Blockade of SDF1/CXCR4-Interaction Inhibits Chronic Transplant Vasculopathy Via Inhibition of VSMC Proliferation.: Abstract# 1217 Poster Board #-Session: P84-III
26. EARLY CONVERSION TO A SIROLIMUS-BASED, CALCINEURIN-INHIBITOR-FREE IMMUNOSUPPRESSION IN THE SMART TRIAL: OBSERVATIONAL RESULTS AT 24 AND 36 MONTHS AFTER TRANSPLANTATION: 066
27. SERUM ERYTHROPOIETIN-LEVELS OF DECEASED ORGAN DONORS (DEPO) ARE PREDICTIVE OF DELAYED GRAFT FUNCTION (DGF) AFTER RENAL TRANSPLANTATION: 103
28. Kapitel 33 - Chronische Nierenerkrankung
29. Effects of Dietary Factors on Drug Transport and Metabolism: The Impact on Dosage Guidelines in Transplant Patients
30. Newly diagnosed and growing subependymal giant cell astrocytoma in adults with tuberous sclerosis complex: Results from the International TOSCA Study
31. Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study
32. Positiver Effekt einer stark verkürzten Kaltischämiezeit bei Nierentransplantationen im Rahmen des ET-Senior-Programms
33. Quantitative gene expression analysis of fractalkine using laser microdissection in biopsies from kidney allografts with acute rejection
34. Kapitel 75 - Chronische Nierenerkrankung
35. Contrast-enhanced ultrasound (CEUS) as a new technique to characterize suspected renal transplant malignancies in renal transplant patients in comparison to standard imaging modalities
36. Vascular rejection in renal transplant: Diagnostic value of contrast-enhanced ultrasound (CEUS) compared to biopsy
37. The diagnostic value of contrast-enhanced ultrasound (CEUS) as a new technique for imaging of vascular complications in renal transplants compared to standard imaging modalities
38. PATIENT AND GRAFT SURVIVAL IN PATIENTS WITH PREVIOUS MALIGNANCIES AFTER CONVERSION MTOR INHIBITOR SIROLIMUS IN A LARGE GERMAN COHORT
39. Analyse flüchtiger organischer und anorganischer Verbindungen in der Atemluft von Hämodialyse-Patienten
40. Tissue sodium content varies interindividually and correlates with glycosaminoglycan expression
41. Ein neues pathophysiologisch ausgerichtetes In-vitro-Modell für Ischämie/Reperfusionsschäden der Niere
42. Etiology of cardiovascular diseases in the transplant population: Will the choice of immunosuppressant matter?
43. Pre- and post-transplant C1q-binding HLA-antibodies affect clinical outcome of renal allografts
44. Therapie der autosomal-dominanten polyzystischen Nierenerkrankung mit Tolvaptan – Einführung in den Umgang mit einer neuen Therapieform
45. Spiegelmer based blockade of SDF1/CXCR4-interaction inhibits chronic transplant vasculopathy by inhibition of vascular smooth muscle cell proliferation
46. PS-049 Analysis of potential drug-drug interactions with immunosuppressive drugs in patients on the waiting list for renal transplantation: Abstract PS-049 Table 1
47. Gynaecomastia following solid organ transplantation
48. The source matters: no impact of the CCL2/MCP-1-1-2518G polymorphism of the donor on renal allograft outcome during the first year after transplantation
49. Antioxidative Vitamine zur Prävention kardiovaskulärer Erkrankungen nach Nierentransplantation und bei chronischer Niereninsuffizienz
50. Membrane and centrifugal therapeutic plasma exchange: practical difficulties in anticoagulating the extracorporeal circuit
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.